Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nextleaf SolutionsSTU:L0MA OCF Margin % is -6.26% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 963 Drug Manufacturers companies, Nextleaf Solutions ranks worse than 66.56% on this metric.
The historical rank and industry rank for Nextleaf Solutions's OCF Margin % or its related term are showing as below:
STU:L0MA'
s OCF Margin % Range Over the Past 10 Years
Min: -1250 Med: -18.19 Max: 10.7
Current: 3.03
During the past 9 years, the highest OCF Margin % of Nextleaf Solutions was 10.70%. The lowest was -1250.00%. And the median was -18.19%.
STU:L0MA's OCF Margin % is ranked worse than 66.56% of 963
companies
in the Drug Manufacturers industry
Industry Median: 10.04
vs STU:L0MA: 3.03
Nextleaf Solutions OCF Margin % Related Terms
Nextleaf Solutions OCF Margin % Historical Data
* Premium members only.
The historical data trend for Nextleaf Solutions's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nextleaf Solutions's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nextleaf Solutions OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nextleaf Solutions's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Nextleaf Solutions's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nextleaf Solutions (STU:L0MA) has a OCF Margin % of -6.26% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nextleaf Solutions and its competitors. According to the industry distribution chart, Nextleaf Solutions ranks #641 out of 963 companies in the Drug Manufacturers industry, placing it in the top 66.6%.
Is Nextleaf Solutions' OCF Margin % too high?
Nextleaf Solutions' current OCF Margin % is -6.26%. Based on the distribution chart, Nextleaf Solutions ranks #641 out of 963 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Nextleaf Solutions' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nextleaf Solutions ranks #641 out of 963 companies for OCF Margin %. This places Nextleaf Solutions in the lower half of its industry. The industry median OCF Margin % is 10.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nextleaf Solutions and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nextleaf Solutions's current OCF Margin % is -6.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nextleaf Solutions stock overvalued right now?
Nextleaf Solutions (STU:L0MA) has a current OCF Margin % of -6.26%. The stock's GF Value™ is €0.02, compared to a current price of €0.02 — trading 10% below its estimated fair value. The current OCF Margin % is -6.26%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nextleaf Solutions (STU:L0MA), the current OCF Margin % is -6.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nextleaf Solutions Ltd is is a Canadian cannabis extractor and processor, with a focus on developing intellectual property for the extraction, distillation formulation, and delivery of cannabinoids. The Company has a single reportable segment being the provision of goods and services to the cannabis industry in Canada. All the Company's revenues are generated in Canada. Revenue from sale of goods and services includes sales of bulk distillate, branded (Glacial Gold) vape pens, oils, and softgels (branded extract products), and private label which includes toll processing and other services. Majority being from Branded extract products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:L0MA has been successfully added to your 
